REAMBERIN for rehydration in diabetic ketoacidosis
Part of Hormones & metabolism clinical trials.
This trial tests a solution called REAMBERIN to help rehydrate people with diabetic ketoacidosis (DKA). If you are 18–75 and have DKA with very high blood sugar and acidic blood, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have type 1 or type 2 diabetes and are in diabetic ketoacidosis (DKA).
- Your blood sugar is very high (over 13.9 mmol/L) and your blood is acidic (pH under 7.25).
- You can start the study treatment within 2 hours after arriving at the hospital.
- You do not have any of the serious health problems listed in the trial (like kidney failure, severe heart disease, or active infections).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an IV medicine called arginine hydrochloride can help manage diabetic ketoacidosis (DKA) in people with type 2 diabetes. It's for those who come to the ER with very high blood sugar and ketones.
This Phase 3 trial tests whether a balanced electrolyte fluid (Plasma-Lyte 148) works better than plain saline for adults with diabetic ketoacidosis (DKA). It may help by improving how quickly and safely your body’s acid/base levels recover during emergency treatment.
This study looks at whether the level of a protein called ferritin in your blood can help predict how well you recover from diabetic ketoacidosis (DKA). If you have DKA and are over 18, you may be able to join.
This trial tests if not eating (fasting) during standard treatment for diabetic ketoacidosis can help patients recover faster or better. It compares the usual treatment to the same treatment without food intake.
This trial tests two types of fluids (saline or Ringer's lactate) to see which works better for people with severe diabetic ketoacidosis. Results could help doctors choose the best fluid replacement in this emergency.
This study looks at how certain people can recover from a dangerous blood-sugar emergency called DKA (diabetic ketoacidosis). Researchers want to understand why some patients improve and how to help them stay healthy long-term.
Hear when a new Diabetic Ketoacidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.